scispace - formally typeset
Search or ask a question

Answers from top 10 papers

More filters
Papers (10)Insight
Exogenous EM-2 in addition to μ-receptors also activates peripheral δ-receptors, which does not involve actions via other opioid peptides.
In particular, and unlike tricyclic antidepressants, it does not act at noradrenergic, muscarinic or histaminergic receptors.
This work alters our understanding of the events that drive the activation of class B receptors.
This recruitment is independent of subunit type, but does require an adequate reserve pool of extrasynaptic receptors.
This does not exclude that these receptors may regulate the release of other neurotransmitters.
Cyanopindolol may act as a partial agonist at these receptors, as it does at the facilitatory prosynaptic β-adrenoceptors.
Therefore, it can be concluded that BQ123 does not act on opioid receptors.
These findings demonstrate that agonist-induced sequestration of receptors does not always lead to desensitization of receptors.
In addition it binds to, but does not affect, the properties of m4 receptors, thereby demonstrating neutral cooperativity and an 'absolute' selectivity of action at m3 receptors over m4 receptors.
However, it does identify certain pharmacological targets that should be investigated further as potential CB3 receptors or channels.

Related Questions

Are there known receptors for oxalate?5 answersYes, there are known receptors for oxalate. Tris(2-aminoethyl)amine (TREN) based pentafluorophenyl urea and 4-cyanophenyl thiourea receptors have shown encapsulation of oxalate in a semi-aqueous environment. Simple TREN-based tripodal urea receptors have also been investigated for the encapsulation of divalent oxalate in a semi-aqueous medium. Additionally, guanidinium is a versatile functional group that can act as an artificial receptor for oxoanions, including oxalate. Furthermore, modified corroles such as oxa corrole and expanded oxacorrole have been shown to act as anion receptors for oxalate. Finally, fluorinated arylboron oxalate based compounds have been designed and synthesized as anion receptors and additives for non-aqueous batteries, enhancing conductivity and lithium ion transference in electrolytes.
What are the chimeric STAR receptors?4 answersChimeric STAR receptors are synthetic T cell receptors (TCRs) and antigen receptors that combine the antigen-recognition domain of an antibody with the constant regions of a TCR. They engage the endogenous CD3 signaling machinery and exhibit TCR-like signaling upon antigen stimulation. STAR receptors, also known as synthetic T-cell receptors and antigen receptors, have been shown to have strong and sensitive signaling capabilities, better proliferation, and less susceptibility to dysfunction compared to traditional CAR-T cells. They also demonstrate higher antigen sensitivity, which may reduce the risk of tumor relapse due to antigen loss. In multiple solid tumor models, STAR-T cells have shown better or equipotent antitumor effects compared to other CAR-T cells without causing notable toxicity.
What are the side effects of EP receptor agonists?5 answersEP receptor agonists have been found to have a high safety profile and exhibit minimal side effects. They are useful as therapeutic agents for various diseases associated with the EP2 receptor, including immune diseases, allergic diseases, nerve cell death, dysmenorrhea, premature delivery, abortion, baldness, eye diseases, erectile dysfunction, arthritis, pulmonary damage, pulmonary fibrosis, pulmonary emphysema, bronchitis, chronic obstructive respiratory diseases, bone diseases, and cartilage damage. Febrile and adrenocortical responses have been observed in prepubertal pigs following injections of EP receptor agonists, but the side effects were not significant.
How to block sugar receptors?10 answers
Is Effexor ER and XR the same?7 answers
What receptors does Keppra work?10 answers

See what other people are reading

Are phytochemicals should not be considered as a replacement for medical treatments or medications?
4 answers
Phytochemicals should not be considered as a direct replacement for medical treatments or medications. While phytochemicals show promise in treating various diseases, including cancer and cardiovascular issues, challenges like toxicity to normal cells, bioavailability issues, and limited clinical evidence hinder their widespread use as standalone therapies. Research emphasizes the importance of evidence-based approaches and the need for clinical demonstration of safety and efficacy in humans before integrating phytochemicals into mainstream medical practice. Phytochemicals derived from plants offer potential as complementary or integrative therapies alongside existing treatments, highlighting their role as adjuncts rather than replacements for conventional medical interventions.
Can p-cresol sulfate bind ary hydrocarbon receptor?
5 answers
p-Cresol sulfate does not bind to the aryl hydrocarbon receptor (AhR) as indoxyl sulfate does. Research has shown that indoxyl sulfate, a uremic toxin, acts as an endogenous ligand for AhR, leading to various biological effects. On the contrary, p-cresol sulfate does not exhibit this property and does not suppress hepatic fetuin-A expression like indoxyl sulfate does. Therefore, while indoxyl sulfate activates AhR and influences vascular inflammation and cardiovascular outcomes, p-cresol sulfate does not have the same impact on AhR activation or related biological pathways. This distinction highlights the specific interactions of different uremic toxins with AhR and their varying effects on physiological processes.
Can p-cresol sulfate interact with ary hydrocarbon receptor?
4 answers
Yes, p-cresol sulfate can interact with the aryl hydrocarbon receptor (AhR) as shown in the research. While p-cresol sulfate itself was not directly studied in relation to AhR activation, the study on indoxyl sulfate (IS)demonstrated that IS, another uremic toxin like p-cresol sulfate, activates AhR. Additionally, the study on p-cresolindirectly supports the potential interaction between p-cresol sulfate and AhR by highlighting the importance of considering variables like pH and photocatalyst amount during the photodegradation process, which could be relevant in understanding the mechanisms of AhR activation by different toxins. Therefore, based on the existing research on related uremic toxins and AhR activation, it is plausible that p-cresol sulfate may also interact with AhR.
WHAT IS THE Helper NLR Model AND DOES IT DIFFER TO THE INTEGRATED DECOY MODEL?
4 answers
The Helper NLR model involves helper NLR proteins that play a crucial role in immune receptor networks by supporting the activation of sensor NLRs and aiding in defense mechanisms against pathogens. These helper NLRs, such as NRG1, interact with other proteins like EDS1 and SAG101 to form complexes that are essential for initiating immune responses. In contrast, the Integrated Decoy model focuses on NLRs containing atypical domains that act as decoys to attract pathogen effectors, triggering specific immune reactions. While both models involve NLR proteins in plant immunity, the Helper NLR model emphasizes the role of helper proteins in supporting immune responses, whereas the Integrated Decoy model highlights the decoy capacity of certain NLRs in detecting and responding to pathogen effectors.
Are there pituicytes in pypothlamus?
10 answers
Pituicytes are specialized glial cells located in the neurohypophysis, also known as the posterior pituitary, rather than in the hypothalamus. These cells are integral to the posterior pituitary's function, engaging in dynamic interactions with neuroendocrine terminals that release vasopressin and oxytocin. Their primary role involves regulating the release of these hormones through various mechanisms, including structural reorganization in response to physiological demands such as dehydration, lactation, and parturition. Pituicytes exhibit a close structural relationship with neurons, forming synaptic contacts that suggest a modulatory role in neurohormone output. Their morphology and activity levels can change significantly under different physiological conditions, indicating their active participation in the neuroendocrine functions of the neurohypophysis. Research has also highlighted the expression of dystrophins and the dystrophin-associated protein complex (DAPC) in pituicytes, suggesting their involvement in cellular structural integrity and possibly in the modulation of hormone release during specific physiological states. Cultured pituicytes have shown the ability to incorporate and potentially regulate the levels of oxytocin and vasopressin, further supporting their role in hormone regulation. Interestingly, studies on the lineage of pituicytes during rodent development have revealed that they may originate from oligodendrocyte precursor cells (OPCs), which are capable of differentiating into various glial cell types, including pituicytes. This finding underscores the diverse potential of OPCs beyond generating myelinating oligodendrocytes. Despite their critical functions within the neurohypophysis, pituicytes do not exhibit structural or numerical modifications in certain genetic conditions affecting glial cells in other parts of the central nervous system (CNS), suggesting a distinct cellular identity and resilience. Additionally, the presence of opiate receptors on pituicytes, rather than on neurosecretory fibers, indicates their involvement in modulating hormone release in response to opiate signals. Collectively, these insights confirm that pituicytes are localized to the posterior pituitary and play a crucial role in the neuroendocrine system, distinct from the hypothalamic functions.
Cannabis vs opioids for pain managment and addiction randomized control trial
5 answers
A randomized control trial comparing cannabis and opioids for pain management and addiction is crucial due to the ongoing debate on their efficacy and safety. While opioids have been traditionally used for pain relief, concerns regarding addiction and adverse effects have led to the exploration of cannabinoids as an alternative. Studies have shown conflicting evidence on the effectiveness of cannabinoids in managing different types of pain, with some suggesting benefits for chronic pain subtypes like neuropathic pain and fibromyalgia. On the other hand, opioids are associated with significant risks, including dose-related issues and challenges in weaning off the medication. Therefore, a randomized trial comparing the two treatments could provide valuable insights into their comparative efficacy, safety, and potential for addiction in pain management.
What is the free ernergy required to activate a piezo2 channel?
5 answers
The free energy required to activate a Piezo2 channel involves various factors such as force transmission pathways, binding affinities of agonists, and intraprotein interactions. Piezo2 is a low-threshold, positive pressure-specific, curvature-sensitive ion channel with a single channel conductance of ~28.6 pS. The activation of Piezo2 by cytoskeleton-transmitted forces requires specific intracellular domains, like IDR5, which fine-tune its sensitivity to mechanical stimuli. Additionally, the mechanogating mechanism of Piezo2 involves charged amino acids at specific interfaces and hydrophobic interactions to ensure normal mechanosensitivity. Understanding these molecular mechanisms and force transmission pathways is crucial for elucidating the free energy requirements for Piezo2 channel activation, contributing to a more sophisticated understanding of its role in touch sensation.
What is the minimum free energy required to activate a piezo1 channel?
5 answers
The minimum free energy required to activate a Piezo1 channel depends on the state of the channel. Experimental and computational studies have shown that Yoda1, a potent Piezo1-selective agonist, binds better to the open state of Piezo1 compared to the closed state, indicating its agonist effects. Additionally, the relative binding free energies of Yoda1 analogs have been found to recapitulate key experimental structure-activity-relationships, aiding in predicting whether a molecule is an agonist or inhibitor of Piezo1. Furthermore, Piezo1 channels can be activated by mechanical stimuli, such as low-intensity pulsed ultrasound, leading to downstream cellular signal processes involving calcium influx and activation of ERK1/2 phosphorylation. These findings collectively suggest that the activation of Piezo1 channels involves complex interactions and energy dynamics influenced by the channel's conformational state and external mechanical stimuli.
What are 3t3 cells?
5 answers
3T3 cells are a type of cell line commonly used in various research fields. These cells are embryonic mouse fibroblast cells that play a crucial role in cell biology studies due to their ability to grow in flat monolayers, making them ideal for cell culture experiments. 3T3 cells have been extensively studied in different contexts, such as investigating transformation, stress fiber formation, and serving as feeder cells for keratinocytes. Additionally, these cells are utilized in experiments related to calcium influx through various receptors, highlighting their significance in understanding cellular signaling pathways. Overall, 3T3 cells are valuable tools in biomedical research, offering insights into cell behavior, culture studies, and signaling mechanisms.
How to increase fat browns?
5 answers
To increase brown fat, various approaches can be considered. One method involves the administration of agents that can induce the transformation of white adipose tissue (WAT) into brown adipose tissue (BAT) by increasing the expression of specific receptors or factors like BDNF, TrkB, or beta-3 adrenergic receptors. Another strategy includes utilizing a tissue-grafting approach where subcutaneous WAT is ex vivo converted to BAT and then re-implanted into the host, a process known as "exBAT," which has shown promising results in both mice and human tissues. Additionally, exposure to cold temperatures through breathing chilled air from a CPAP machine while sleeping can also stimulate brown fat development and activity, leading to increased caloric expenditure and potential weight loss. These methods collectively aim to enhance brown fat activity and its beneficial metabolic effects.
How to make plate bound antigen synnotch?
5 answers
To create plate-bound antigen synNotch receptors, a novel approach involves utilizing a switchable adaptor receptor system where receptor specificity can be post-translationally directed by covalently attaching a co-administered antibody containing a benzylguanine (BG) motif. This system incorporates the SNAPtag self-labeling enzyme, which reacts with BG-conjugated antibodies to assemble covalently-associated antigen receptors, allowing for precise antigen recognition and activation of downstream effector functions. By genetically fusing the SNAPtag enzyme to the receptor, plate-bound antigen synNotch receptors can be successfully targeted by clinically relevant BG-conjugated antibodies, demonstrating the potential for effective antigen-specific responses. This innovative strategy provides a powerful means to reprogram the targeting specificity of engineered cells, enhancing the versatility and efficacy of synthetic Notch receptor systems in therapeutic applications.